CyberArk
Case Studies
Pharmaceutical Leader AstraZeneca Collaborates Securely
Overview
Pharmaceutical Leader AstraZeneca Collaborates SecurelyCyberArk |
Cybersecurity & Privacy - Identity & Authentication Management Cybersecurity & Privacy - Security Compliance Application Infrastructure & Middleware - Data Exchange & Integration | |
Pharmaceuticals Healthcare & Hospitals | |
Business Operation Product Research & Development | |
Remote Collaboration | |
System Integration Software Design & Engineering Services | |
Operational Impact
CyberArk’s Sensitive Information Management solution enabled AstraZeneca to exchange data and documents more quickly with business partners, significantly speeding up the drug development process. | |
The solution's powerful version-control mechanism protects against deliberate and unintentional data corruption, ensuring data integrity. | |
The ease of deployment and maintenance of CyberArk’s solution reduced the high-management burden previously experienced with the in-house application. | |
Quantitative Benefit
AstraZeneca invested $3.8 billion into new drug research and development in 2004. | |
The company employs 11,900 people dedicated to drug and treatment research and development. | |
It is estimated that it costs pharmaceutical companies $1 million for each day a drug is under development. | |